tirzepatide approval canada B.C. limits sale of 2 more diabetes drugs used for weight loss π GLP-1 Injectable Options in
Description
CHEMICAL STRUCTURE CAS Number : 2023788-19-2 Molecular Formula : C 225 H 348 N 48 O 68 Molecular Weight : ~4813 Da Molar Mass Structure : Synthetic 39-amino acid peptide Peptide Sequence: His-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Glu-Glu-Glu-Glu-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH
This makes pharmacological sense
Early communication helps prevent a small issue from becoming a reason to stop treatment altogether

Additionally, restarting home medications before discharge improves transitions of care
Tirzepatide wins on weight loss efficacy, A1C reduction, injection convenience, side effect tolerability, and increasingly on cost